Axsome Therapeutics (AXSM) P/BV US GAAP (year values) |
||||||||
| 2022 | 2022 | 2023 | 2024 | 2025 | LTM ? | |||
| P/BV | ? | 79.2 | 79.2 | 28.8 | -2 110 | 254.3 | 916.7 | |
| Changes by years, y/y, % | -13% | +0% | -64% | -7 434% | -112% | |||
Axsome Therapeutics. P/BV
Axsome Therapeutics. P/BV, changes, %
Axsome Therapeutics (AXSM) P/BV US GAAP (quarter values) |
||||||||
| 2025Q1 | 2025Q2 | 2025Q3 | 2025Q4 | 2026Q1 | LTM ? | |||
| P/BV | ? | -1 370 | 298.3 | 310.6 | 258.8 | 2 405 | 916.7 | |
| Changes by years, y/y, % | -3 010% | +217% | +132% | -112% | -275% | |||
| Changes by quarters, q/q, % | -36% | -122% | +4% | -17% | +829% | |||